The Systems Biology Institute
Tokyo, Japan
The Systems Biology Institute (SBI) is a non-profit private research institution established in 2000 by Hiroaki Kitano with the aim of promoting systems biology research and its application to medicine and global sustainability. SBI was established to promote systems biology research in some of critical areas for healthcare and global sustainability. Currently, SBI is engaged in a series of research program largely funded by branches of Japanese government, such as Japan Science and Technology Agency (JST), New Energy Development Organization (NEDO), and Ministry of Education, Sports, Culture, Science, and Technology (MEXT), but also work on private contract for industrial applications of systems biology research in drug discovery and other areas.
Research Topics Currently Explored at The SBI
- Computational Platform for Systems Biology (CPSB)
- SBML
- SBGN
- CellDesigner™
- Large-scale mapping of molecular interactions
- Payao/Payaologue - community-based biological knowledge aggregation system
- Text mining for pathway curation
- Analysis platform for Influenza Infection-induced host response
- Theoretical Studies
- Biological Robustness
- Systems Drug and Therapy Design
- Multi-component drugs
- Anti-cancer drugs
- Theory of Cancer Robustness
- Yeast Systems Biology
- Systems Biology of Coral Reefs
Contact person for outreach:
- info at sbi.jp
Dr. Hiroaki Kitano, Director
Falcon Building 5F, 5-6-9 Shirokanedai, Minato, Tokyo - 108-0071 Japan
- www.sbi.jp